BeOne Medicines initiates trial for BG-75098 in advanced solid tumors
A clinical trial is underway to assess the safety and efficacy of BG-75098, both alone and in combination with other agents.
Asset / Drug
Drug and asset intelligence for BGB-43395 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.